BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15583857)

  • 21. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expression of GDNF (glial cell line-derived neurotrophic factor) and Ret in normal human and cancerous pancreatic tissues].
    Kikuchi K
    Hokkaido Igaku Zasshi; 2004 Sep; 79(5):585-95. PubMed ID: 15540663
    [No Abstract]   [Full Text] [Related]  

  • 23. Protein tyrosine kinases and cancer.
    Kolibaba KS; Druker BJ
    Biochim Biophys Acta; 1997 Dec; 1333(3):F217-48. PubMed ID: 9426205
    [No Abstract]   [Full Text] [Related]  

  • 24. HIP1: trafficking roles and regulation of tumorigenesis.
    Hyun TS; Ross TS
    Trends Mol Med; 2004 Apr; 10(4):194-9. PubMed ID: 15059611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intercellular signalling. The pros and cons of c-ret.
    Dressler GR
    Curr Biol; 1994 Apr; 4(4):354-6. PubMed ID: 7922346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and physiology of the RET receptor tyrosine kinase.
    Ibáñez CF
    Cold Spring Harb Perspect Biol; 2013 Feb; 5(2):. PubMed ID: 23378586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juxtamembrane autoinhibition in receptor tyrosine kinases.
    Hubbard SR
    Nat Rev Mol Cell Biol; 2004 Jun; 5(6):464-71. PubMed ID: 15173825
    [No Abstract]   [Full Text] [Related]  

  • 28. RET-fusions: a novel paradigm in colorectal cancer.
    Santos C; Sanz-Pamplona R; Salazar R
    Ann Oncol; 2018 Jun; 29(6):1340-1343. PubMed ID: 29648570
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity.
    Ancot F; Foveau B; Lefebvre J; Leroy C; Tulasne D
    Oncogene; 2009 Jun; 28(22):2185-95. PubMed ID: 19421148
    [No Abstract]   [Full Text] [Related]  

  • 30. Signaling by the sea.
    Lemmon MA; Smerdon SJ
    Nat Struct Mol Biol; 2004 Aug; 11(8):682-5. PubMed ID: 15280876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the Genetic Paradigm of Cancer Complete?
    Gatenby RA
    Radiology; 2017 Jul; 284(1):1-3. PubMed ID: 28628406
    [No Abstract]   [Full Text] [Related]  

  • 32. Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.
    De Martino M; Esposito F; Capone M; Pallante P; Fusco A
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance.
    Zhu J; Liu C; Wang D; Cao X; Wang S; Liu Y; Wang J; Li P; He Q
    Front Oncol; 2021; 11():706011. PubMed ID: 34447696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies.
    Boi F; Pani F; Mariotti S
    Eur Thyroid J; 2017 Jul; 6(4):178-186. PubMed ID: 28868258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.
    Jorgensen EM; Alderman MH; Taylor HS
    FASEB J; 2016 Sep; 30(9):3194-201. PubMed ID: 27312807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial syndromes associated with neuroendocrine tumours.
    Gut P; Komarowska H; Czarnywojtek A; Waligórska-Stachura J; Bączyk M; Ziemnicka K; Fischbach J; Wrotkowska E; Ruchała M
    Contemp Oncol (Pozn); 2015; 19(3):176-83. PubMed ID: 26557756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulation of microRNA expression in thyroid neoplasias.
    Pallante P; Battista S; Pierantoni GM; Fusco A
    Nat Rev Endocrinol; 2014 Feb; 10(2):88-101. PubMed ID: 24247220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation in thyroid oncogenesis.
    Liotti F; Visciano C; Melillo RM
    Am J Cancer Res; 2012; 2(3):286-97. PubMed ID: 22679559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET PLCγ phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration.
    Lundgren TK; Nakahata K; Fritz N; Rebellato P; Zhang S; Uhlén P
    PLoS One; 2012; 7(2):e31258. PubMed ID: 22355350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.
    Barr J; Amato CM; Robinson SE; Kounalakis N; Robinson WA
    Melanoma Res; 2012 Feb; 22(1):92-5. PubMed ID: 22189301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.